Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...

The stock ended at ₹562 on the NSE, down ₹38 or 6.33%, and at ₹557.80 on the BSE, down ₹35.90 or 6.05%. During the day, the ...

Senores Pharmaceuticals share price listed at stellar 53% premium at ₹600 on the NSE and ₹593.70 on the BSE on Monday ...

Senores Pharmaceuticals Share Price, IPO Listing Live Updates: Senores Pharma IPO debuts Dec 30, oversubscribed 97.86x. Check ...

Senores Pharmaceuticals share price listed on the NSE at ₹600 apiece while it opened on the BSE at ₹593.70 per share mark ...

Shares of Senores Pharmaceuticals are scheduled to be listed on the stock exchanges today on Monday, December 30, following a ...

The issue had opened for public subscription on December 20 to raise about ₹582 crore from the primary market.

At the upper price band, the company is valued at a P/E of 55x with a market cap of Rs 1800.6 crore (Image: Freepik) The ...

Ahmedabad-based Senores Pharmaceuticals raised Rs 582.11 crore through its IPO, which comprised a fresh issue of Rs 500 crore and an offer-for-sale of Rs 82.11 crore.

Senores Pharmaceuticals IPO sees robust demand, with potential listing gain of 59%, scheduled to list on BSE and NSE.

Senores Pharmaceuticals shares opened at Rs 600 on the National Stock Exchange at a premium of 53.45% over its IPO price of ...

Unlisted shares of Senores Pharmaceuticals were trading at Rs 631 per share, reflecting a GMP of Rs 240 per share or 61.38 ...